Kevin Kotler

Kevin Kotler

Chief Executive Officer at Broadfin Capital LLC

Net worth: 75 M $ as of 30/04/2024

53 year
Finance
Health Technology
Consumer Services

Profile

Mr. Kevin Kotler is an Independent Director at BioDelivery Sciences International, Inc., a Managing Partner & Portfolio Manager at Broadfin Capital LLC and a Principal at Broadfin Healthcare Fund LP.
He is on the Board of Directors at Avadel Pharmaceuticals Plc, BioDelivery Sciences International, Inc., InnerSpace Neuro Solutions, Inc. and Broadfin Healthcare Offshore Fund Ltd.
He has over 24 years of experience as an investor in the medical technology industry.
Mr. Kotler began his investment career as a Research Associate at Furman Selz (1993-1994) and moved to UBS as a junior medical technology and supplies analyst (1994-1998) focusing on small capitalization companies across a number of medical specialties.
From UBS, he moved to ING (1998-2002), where he assumed greater responsibility as a senior medical technology and supplies analyst.
He continued with ING through its acquisition by ABN AMRO and remained there until he was recruited to The Galleon Group (2002-2005) where he ran a healthcare carve out and was a research analyst in the Firm’s healthcare fund.
In July 2005, he left to form Broadfin Capital.
He graduated from the Wharton School at the University of Pennsylvania in 1993 with a Bachelor of Science degree in Economics.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/02/2024 3,716,242 ( 4.10% ) 66 M $ 30/04/2024
27/03/2024 1,899,930 ( 6.30% ) 7 M $ 30/04/2024
18/04/2023 540,000 ( 0.36% ) 1 M $ 30/04/2024

Kevin Kotler active positions

CompaniesPositionStart
Chief Executive Officer 01/06/2005
Corporate Officer/Principal -
Director/Board Member 23/04/2009
Director/Board Member 01/01/2014
Curonix Director/Board Member -
All active positions of Kevin Kotler

Former positions of Kevin Kotler

CompaniesPositionEnd
HERON THERAPEUTICS, INC. Director/Board Member 31/12/2023
BIODELIVERY SCIENCES INTERNATIONAL, INC. Director/Board Member 22/03/2022
AVADEL PHARMACEUTICALS PLC Director/Board Member 01/10/2019
NOVELION THERAPEUTICS INC. Director/Board Member 24/09/2018
░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Kevin Kotler's experience

Training of Kevin Kotler

University of Pennsylvania Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Kotler's experience

Connections

100 +

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
HERON THERAPEUTICS, INC.

Health Technology

AVADEL PHARMACEUTICALS PLC

Health Technology

Private companies11

Finance

Health Technology

Finance

Finance

Finance

Furman Selz LLC

Finance

Finance

Electronic Technology

Health Technology

Hamptons

Curonix

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW